Recombinant Mouse Fzd7 is a bioengineered version of the endogenous Frizzled-7 receptor, produced via heterologous expression systems. Key characteristics include:
The CRD (aa 44–169) binds Wnt ligands and co-receptors like LRP5/6, while the transmembrane domains enable signal transduction .
Recombinant Fzd7 is used in diverse functional studies:
Embryonic Stem Cell Maintenance: Fzd7 knockout in human ESCs disrupts self-renewal, while recombinant Fzd7 restores Wnt/β-catenin signaling .
Mesendoderm Differentiation: Engineered F7L6 (Fzd7/LRP6-binding protein) induces primitive streak-like transcription in hPSCs, bypassing CRD dependency .
Fzd7 is a target in cancer due to its overexpression in tumors and role in β-catenin-independent signaling:
Gene Therapy: pFZD7-driven expression of Shiga-like toxin I (Stx1) selectively kills Fzd7-positive cancer cells .
Antibody-Based Therapies: Neutralizing antibodies (e.g., AF198) inhibit Wnt signaling in preclinical models .
Mouse Frizzled-7 (accession number Q61090) functions as a receptor for Wnt proteins. It belongs to a distinct subfamily within the Frizzled family of Wnt receptors, clustered with Fz1 and Fz2 . Most frizzled receptors, including Fzd7, are coupled to the β-catenin canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of β-catenin, and activation of Wnt target genes . Following ligand activation, Fzd7 binds to CCDC88C/DAPLE, which displaces DVL1 and leads to inhibition of canonical Wnt signaling, activation of G-proteins, and triggering of non-canonical Wnt responses .
Frizzled-7 forms a distinct subfamily with Frizzled-1 and Frizzled-2 based on sequence homology and functional redundancy . In vitro experiments indicate that both Fz2 and Fz7 are competent to signal via the canonical pathway . Unlike some other Frizzled receptors that may predominantly signal through either canonical or non-canonical pathways, Fzd7 appears versatile, participating in both the β-catenin canonical pathway and a second signaling pathway involving PKC and calcium fluxes . This dual signaling capability makes Fzd7 particularly interesting for studying pathway crosstalk and context-dependent signaling outcomes.
X-Gal staining of Fz7^lacZ/lacZ embryos at E8.5 and E9.5 shows widespread expression of the lacZ reporter, including throughout the developing nervous system and somites . This pattern closely resembles the embryonic expression patterns observed for Fz1 and Fz2 alleles, suggesting potential functional redundancy during development . The expression can be detected in embryonic mouse gastrointestinal tract (11 d.p.c.) using immunohistochemistry techniques with appropriate antibodies .
For detecting endogenous Frizzled-7 in tissues, multiple validated approaches exist:
Western Blot (WB): Successful detection has been reported in mouse skeletal muscle, heart, and kidney tissues using a dilution range of 1:500-1:2000 . For optimal results, non-reducing conditions may preserve the native structure of Frizzled-7, as demonstrated in some studies .
Immunohistochemistry (IHC): Effective detection in tissues such as human small intestine and mouse embryonic gastrointestinal tract using a dilution of 1:400-1:1600 . Antigen retrieval with TE buffer pH 9.0 is recommended, though citrate buffer pH 6.0 may also be effective .
Immunoprecipitation (IP): Can be performed using 0.5-4.0 μg of antibody for 1.0-3.0 mg of total protein lysate, with successful detection reported in mouse skeletal muscle tissue .
Immobilized Human Frizzled-7 with His Tag at 5 μg/mL (100 μL/well) can bind Wnt surrogate proteins with a linear range of 1-16 ng/mL . When using biotinylated binding partners such as Glypican 3 loaded on SA Biosensor, Frizzled-7 binding affinity can be determined using bio-layer interferometry (BLI) assays, with reported affinity constants around 1.18 μM . These quantitative binding assays provide important insights into receptor-ligand interactions that underpin Wnt signaling pathways.
Knockdown studies have demonstrated that siRNA targeting FZD7 leads to significant reduction in growth of embryonal carcinoma (EC) cells . In NT2/D1 cells, FZD7 knockdown resulted in decreased cell numbers after 4 days compared to controls, with statistical significance (p < 0.005) . Similar effects were observed in cisplatin-resistant NT2/D1-R1 cells, suggesting that Frizzled-7 signaling may be important for maintaining proliferation in both sensitive and drug-resistant cellular contexts . These findings highlight the potential therapeutic relevance of targeting Frizzled-7 in certain cancer types.
Distinguishing between canonical and non-canonical signaling downstream of Frizzled-7 requires multi-faceted experimental approaches:
Transcriptional reporters: TOPFlash/FOPFlash luciferase assays can measure β-catenin-dependent transcriptional activation as a readout of canonical signaling.
Protein localization: Immunofluorescence detection of β-catenin nuclear translocation indicates canonical pathway activation.
Calcium imaging: Since Frizzled-7 can activate a second signaling pathway involving calcium fluxes, calcium indicators can monitor non-canonical pathway activation .
Co-immunoprecipitation: Detecting CCDC88C/DAPLE binding to Frizzled-7, which displaces DVL1 and inhibits canonical signaling while promoting non-canonical responses .
G-protein activation assays: Measuring GTPase activity can indicate activation of non-canonical pathways, as Frizzled-7 interactions with G-proteins have been implicated in both signaling routes .
Addressing functional redundancy between Frizzled-7 and related receptors requires strategic experimental approaches:
Combinatorial knockouts: Generate and analyze double knockout models (e.g., Fz2^-/-;Fz7^-/-) to reveal phenotypes masked by redundancy .
Conditional tissue-specific knockouts: Target specific tissues or developmental timepoints to bypass early lethality that may result from complete knockout of redundant receptors.
Domain swapping experiments: Create chimeric receptors to identify which regions confer functional specificity versus redundancy.
Ligand specificity analysis: Systematically test all pairwise combinations of Frizzleds and Wnts, as has been done for canonical signaling, to map receptor-ligand selectivity .
Expression correlation analysis: Examine co-expression patterns of Frizzled family members across tissues to identify potential compensatory mechanisms.
Genetic interactions between Fz7 and other developmental genes reflect complex signaling networks:
Interaction with Vangl2: As a component of the planar cell polarity pathway, Vangl2 interacts with Frizzled signaling in processes such as convergent extension .
Interaction with Dvl3: Dishevelled proteins act downstream of Frizzled receptors in both canonical and non-canonical pathways, mediating signal transduction .
Interaction with Wnt ligands: Different Wnt ligands can preferentially activate canonical versus non-canonical pathways through the same Frizzled receptor, depending on co-receptor availability and cellular context .
These interactions highlight how Frizzled-7 functions within integrated signaling networks rather than in isolation, with significant implications for developmental processes and disease mechanisms when these networks are perturbed.